Eli Lilly and Company

11/14/2026 | Press release | Distributed by Public on 11/14/2026 12:16

Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Eli Lilly and Company published this content on November 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 14, 2026 at 18:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]